Related resources
Full-text held externally
- DOI: 10.1159/000091898
Search for item elsewhere
University researcher(s)
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia.
Peters, F, Perani, D, Herholz, KG, Holthoff, V, Beuthien-Baumann, B, Sorbi, S, Pupi, A, Degueldre, C, Lemaire, C, Collette, F, Salmon, E
Dement Geriatr Cogn Disord. 2006;21( 5-6):373-9.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Full-text is available externally using the following links:
Full-text held externally
- DOI: 10.1159/000091898
Abstract
Orbitofrontal metabolic impairment is characteristic of the frontal variant of frontotemporal dementia (fv-FTD), as are early changes in emotional and social conduct. Two main types of behavioral disturbances have been distinguished in fv-FTD patients: apathetic and disinhibited manifestations. In this study, we searched for relationships between brain metabolism and presence of apathetic or disinhibited behavior. Metabolic activity and behavioral data were collected in 41 fv-FTD patients from European PET centers. A conjunction analysis of the PET data showed an expected impairment of metabolic activity in the anterior cingulate, ventromedial and orbital prefrontal cortex, the dorsolateral prefrontal cortex and the left anterior insula in fv-FTD subjects compared to matched controls. A correlation was observed between disinhibition scores on the Neuropsychiatric Inventory scale and a cluster of voxels located in the posterior orbitofrontal cortex (6, 28, -24). Comparison of brain activity between apathetic and nonapathetic fv-FTD patients from two centers also revealed a specific involvement of the posterior orbitofrontal cortex in apathetic subjects (4, 22, -22). The results confirm that the main cerebral metabolic impairment in fv-FTD patients affects areas specializing in emotional evaluation and demonstrate that decreased orbitofrontal activity is related to both disinhibited and apathetic syndromes in fv-FTD. Copyright (c) 2006 S. Karger AG, Basel.
Keyword(s)
Aged; Female; Humans; Inhibition (Psychology); Male; Neuropsychological Tests; Positron-Emission Tomography; Research Support, Non-U.S. Gov't; Severity of Illness Index; diagnosis: Cognition Disorders; diagnosis: Depression; diagnostic use: Fluorodeoxyglucose F18; diagnostic use: Radiopharmaceuticals; metabolism: Frontal Lobe; metabolism: Temporal Lobe; pathology: Dementia; physiopathology: Prefrontal Cortex